Publications by authors named "M S Morozova"

Objective: to study the level of psychosocial strain in the able-bodied population of the NPP surveillance zone (SZ) and factors that shape it under the wartime posture and possible terrorist acts.

Methods: sociological (population survey), psychosocial (psychodiagnostic testing), analytical, mathematical i.e.

View Article and Find Full Text PDF

Mental imagery is a crucial cognitive process, yet its underlying neural mechanisms remain less understood compared to perception. Furthermore, within the realm of mental imagery, the somatosensory domain is particularly underexplored compared to other sensory modalities. This study aims to investigate the influence of tactile imagery (TI) on cortical somatosensory processing.

View Article and Find Full Text PDF

Spinal muscular atrophy (SMA) is a group of genetically heterogeneous neuromuscular diseases characterized by the progressive loss of motor neurons in the anterior horns of the spinal cord. The prevalence of SMA is approximately 1 in 10.000 live births.

View Article and Find Full Text PDF

This perspective considers the novel concept of olfactory neurofeedback (O-NFB) within the framework of brain-computer interfaces (BCIs), where olfactory stimuli are integrated in various BCI control loops. In particular, electroencephalography (EEG)-based O-NFB systems are capable of incorporating different components of complex olfactory processing - from simple discrimination tasks to using olfactory stimuli for rehabilitation of neurological disorders. In our own work, EEG theta and alpha rhythms were probed as control variables for O-NFB.

View Article and Find Full Text PDF

Objective: To assess the possibility of achieving physiological ketosis with oral administration of beta-hydroxybutyrate salts and, if ketosis is achieved, to assess its effect on cognitive functioning in patients with brain dysfunction during the recovery period after a somatic disease.

Material And Methods: The study included 86 patients with complaints of asthenic manifestations (ICD-10 diagnoses F06; F07; R53). Half of the patients were included in the study group taking beta-hydroxybutyrate salts, and the other half were included in the control group taking placebo.

View Article and Find Full Text PDF